158 studies found for:    "Rothmund-Thomson Syndrome"
Show Display Options
Download search resultsDownload the search results for:
"Rothmund-Thomson Syndrome" (158 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Enrolling by invitation Calcium Absorption in Patients With Rothmund-Thomson Syndrome
Condition: Rothmund-Thomson Syndrome
Intervention:
2 Terminated Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Condition: Idiopathic Interstitial Pneumonias
Intervention:
3 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
4 Recruiting A Linkage and Association Study in Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
5 Recruiting Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Conditions: Muscular Dystrophy;   Congenital Muscular Dystrophy;   Fukutin-related Protein Gene;   Limb Girdle;   FKRP Gene;   Childhood Onset LGMD;   Adult Onset LGMD;   POMT1;   POMT2;   POMGnT1;   LARGE;   Alpha Dystroglycan;   Dystroglycanopathy;   Centronuclear;   Multiminicore;   Multicore;   Minicore;   Congenital Fiber Type Disproportion;   Myotubular;   Nemaline;   Congenital Myopathy;   Neuromuscular;   Rigid Spine;   Phenotype-Genotype Correlation;   Cough Assisted Device;   Neuromuscular Disease;   Respiratory Exacerbation;   Invasive Ventilation;   Chest Physiotherapy;   Congenital Myopathies;   Genetic Mutations;   Hypertrophic Cardiomyopathy;   Wheelchair Use;   Cataract;   Opthalmoplegia;   Ullrich Congenital Muscular Dystrophy;   Intermediate Collagen VI Myopathy;   Laminin Alpha 2 Related Congenital Muscular Dystrophy;   MDC1A;   Merosin Deficient Congenital Muscular Dystrophy;   Congenital Muscular Dystrophy Undiagnosed;   Congenital Muscular Dystrophy Merosin Positive;   Walker Warburg Syndrome;   Muscle Eye Brain Disease;   Fukuyama;   Integrin Alpha 7 Deficiency;   Integrin Alpha 9 Deficiency;   Laminopathy;   Lamin AC;   SEPN 1 Related Myopathies;   Bethlem Myopathy;   Dystroglycanopathies;   LGMD2K;   LGMD2I;   LGMD2L;   LGMD2N;   Actin Aggregation Myopathy;   Cap Disease;   Central Core Disease;   Centronuclear Myopathy;   Core Rod Myopathy;   Hyaline Body Myopathy;   Multiminicore Myopathy;   Myotubular Myopathy;   Nemaline Myopathy;   Tubular Aggregate Myopathy;   Zebra Body Disease Myopathy;   Congenital Myopathy Other;   Reducing Body Myopathy;   Sarcotubular Myopathy;   Spheroid Body Myopathy
Intervention:
6 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
7 Completed
Has Results
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
Conditions: Alveolitis, Fibrosing;   Fibrosis, Pulmonary;   Hypertension, Pulmonary
Intervention: Drug: sildenafil
8 Unknown  Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
Conditions: Emphysema;   Alveolitis, Fibrosing;   Cystic Fibrosis;   Bronchiectasis;   Lung Diseases
Intervention: Procedure: Pulmonary rehabilitation programme
9 Recruiting Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Condition: Progeria
Intervention: Drug: Lonafarnib, Zoledronic Acid, and Pravastatin
10 Completed A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Condition: Progeria
Interventions: Drug: Lonafarnib;   Drug: Zoledronic Acid;   Drug: Pravastatin
11 Unknown  Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
Conditions: Progeria;   Hutchinson-Gilford Syndrome
Intervention: Drug: Lonafarnib
12 Recruiting Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
13 Unknown  Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients
Conditions: Idiopathic Pulmonary Fibrosis;   Cough;   Breathlessness
Intervention: Behavioral: Cognitive behavioural therapy
14 Active, not recruiting Long-Term Safety Study of GS-6624 to Treat Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Simtuzumab
15 Recruiting Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
16 Recruiting Idiopathic Pulmonary Fibrosis Registry for Future Studies
Conditions: Lung Disease, Interstitial;   Idiopathic Pulmonary Fibrosis
Intervention:
17 Active, not recruiting Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis
Interventions: Drug: Sildenafil;   Drug: Losartan;   Drug: Sildenafil and Losartan;   Drug: Placebo pill
18 Completed
Has Results
Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Placebo
19 Terminated
Has Results
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Hypertension
Interventions: Drug: Ambrisentan;   Drug: Placebo
20 Not yet recruiting Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Dyspnoea;   Anxiety;   Depression
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years